# BriaCell Therapeutics Corp.: filings

BCTX · Nasdaq · CIK 1610820 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jul 31

Pages: [Overview](/companies/bctx.md) · [Financials](/companies/bctx/financials.md) · [Filings](/companies/bctx/filings.md) · [Insiders](/companies/bctx/insiders.md)

## Reports and events: 149 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 65, 6-K 51, CORRESP 32, F-1/A 15, UPLOAD 14, SC 13G 13, 10-Q 12, SC 13G/A 11, 3 10, EFFECT 9, 424B5 8, SCHEDULE 13G 7, 424B4 6, DEF 14A 5, 10-K 4, 4 4, 424B3 4, D 4, DRS 4, FWP 4, SC 13D/A 4, 8-A12B 3, CERT 3, DRSLTR 3, POS AM 3, S-1 3, S-1/A 3, SCHEDULE 13G/A 3, F-1 2, PRE 14A 2, S-1MEF 2, 25-NSE 1, 40-F 1, 40-F/A 1, DEFA14A 1, DEL AM 1, S-3 1, S-8 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-06-26 | 16:05 ET | [8-K](/filings/0001493152-26-030286.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-030286 |
| 2026-06-09 | 16:06 ET | [10-Q](/filings/0001493152-26-027928.md) | Quarterly report, period 2026-04-30 | 0001493152-26-027928 |
| 2026-06-03 | 21:32 ET | [8-K](/filings/0001493152-26-026953.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-026953 |
| 2026-03-31 | 16:10 ET | [8-K](/filings/0001493152-26-014156.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-014156 |
| 2026-03-10 | 17:08 ET | [10-Q](/filings/0001493152-26-009557.md) | Quarterly report, period 2026-01-31 | 0001493152-26-009557 |
| 2026-03-09 | 16:52 ET | [8-K](/filings/0001493152-26-009382.md) | 5.07 Shareholder vote results | 0001493152-26-009382 |
| 2026-02-20 | 16:00 ET | [8-K](/filings/0001493152-26-007587.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-007587 |
| 2026-02-12 | 16:00 ET | [DEF 14A](/filings/0001493152-26-006390.md) | Proxy statement, period 2026-02-12 | 0001493152-26-006390 |
| 2026-01-15 | 16:15 ET | [8-K](/filings/0001493152-26-002430.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-002430 |
| 2025-12-29 | 16:05 ET | [8-K](/filings/0001493152-25-029363.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-029363 |
| 2025-12-23 | 08:21 ET | [S-1](/filings/0001493152-25-028916.md) | Registration statement | 0001493152-25-028916 |
| 2025-12-11 | 16:05 ET | [10-Q](/filings/0001493152-25-027240.md) | Quarterly report, period 2025-10-31 | 0001493152-25-027240 |
| 2025-12-01 | 20:15 ET | [8-K](/filings/0001493152-25-025469.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-025469 |
| 2025-10-16 | 20:46 ET | [10-K](/filings/0001493152-25-018212.md) | Annual report, period 2025-07-31 | 0001493152-25-018212 |
| 2025-08-26 | 20:18 ET | [8-K](/filings/0001641172-25-025438.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-025438 |
| 2025-07-16 | 16:15 ET | [8-K](/filings/0001641172-25-019892.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-019892 |
| 2025-07-10 | 17:29 ET | [S-1/A](/filings/0001641172-25-018633.md) | Registration statement, amended | 0001641172-25-018633 |
| 2025-07-09 | 13:05 ET | [S-1/A](/filings/0001641172-25-018347.md) | Registration statement, amended | 0001641172-25-018347 |
| 2025-07-08 | 16:08 ET | [S-1](/filings/0001641172-25-018193.md) | Registration statement | 0001641172-25-018193 |
| 2025-06-18 | 08:27 ET | [8-K](/filings/0001641172-25-015516.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-015516 |
| 2025-06-16 | 16:34 ET | [10-Q](/filings/0001641172-25-015265.md) | Quarterly report, period 2025-04-30 | 0001641172-25-015265 |
| 2025-04-28 | 16:15 ET | [8-K](/filings/0001641172-25-006428.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-006428 |
| 2025-04-23 | 16:51 ET | [S-1/A](/filings/0001641172-25-005871.md) | Registration statement, amended | 0001641172-25-005871 |
| 2025-04-22 | 16:02 ET | [S-1](/filings/0001641172-25-005677.md) | Registration statement | 0001641172-25-005677 |
| 2025-03-12 | 16:22 ET | [10-Q](/filings/0001493152-25-010052.md) | Quarterly report, period 2025-01-31 | 0001493152-25-010052 |
| 2025-03-12 | 16:00 ET | [8-K](/filings/0001493152-25-010035.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-010035 |
| 2025-02-13 | 16:00 ET | [8-K](/filings/0001493152-25-006419.md) | 8.01 Other events | 0001493152-25-006419 |
| 2025-02-06 | 16:30 ET | [8-K](/filings/0001493152-25-005204.md) | 5.07 Shareholder vote results | 0001493152-25-005204 |
| 2025-02-05 | 17:02 ET | [8-K](/filings/0001493152-25-005043.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-005043 |
| 2025-01-28 | 16:00 ET | [8-K](/filings/0001493152-25-003977.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-003977 |
| 2025-01-03 | 17:00 ET | [8-K](/filings/0001493152-25-000281.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-000281 |
| 2025-01-03 | 17:00 ET | [8-K](/filings/0001493152-25-000282.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-000282 |
| 2024-12-17 | 16:05 ET | [DEF 14A](/filings/0001493152-24-050399.md) | Proxy statement, period 2024-12-17 | 0001493152-24-050399 |
| 2024-12-16 | 16:05 ET | [10-Q](/filings/0001493152-24-050214.md) | Quarterly report, period 2024-10-31 | 0001493152-24-050214 |
| 2024-12-16 | 16:05 ET | [8-K](/filings/0001493152-24-050212.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-050212 |
| 2024-12-13 | 16:15 ET | [8-K](/filings/0001493152-24-049999.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-049999 |
| 2024-12-12 | 06:06 ET | [SC 13D/A](/filings/0001493152-24-049719.md) | Ownership report, active investor, amended | 0001493152-24-049719 |
| 2024-12-10 | 06:06 ET | [SC 13D/A](/filings/0001493152-24-049352.md) | Ownership report, active investor, amended | 0001493152-24-049352 |
| 2024-12-05 | 07:45 ET | [SC 13D/A](/filings/0001493152-24-048801.md) | Ownership report, active investor, amended | 0001493152-24-048801 |
| 2024-11-25 | 16:00 ET | [8-K](/filings/0001493152-24-047606.md) | 5.02 Departure or appointment of officers or directors | 0001493152-24-047606 |
| 2024-11-01 | 16:05 ET | [8-K](/filings/0001493152-24-043322.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-043322 |
| 2024-10-29 | 18:22 ET | [10-K](/filings/0001493152-24-042743.md) | Annual report, period 2024-07-31 | 0001493152-24-042743 |
| 2024-10-02 | 16:30 ET | [8-K](/filings/0001493152-24-039218.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-039218 |
| 2024-10-01 | 16:02 ET | [8-K](/filings/0001493152-24-039016.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-039016 |
| 2024-09-12 | 16:25 ET | [8-K](/filings/0001493152-24-036055.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-036055 |
| 2024-09-11 | 08:50 ET | [8-K](/filings/0001493152-24-035737.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-035737 |
| 2024-08-23 | 17:00 ET | [8-K](/filings/0001493152-24-033753.md) | 3.01 Delisting notice | 0001493152-24-033753 |
| 2024-07-18 | 16:30 ET | [8-K](/filings/0001493152-24-028343.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-028343 |
| 2024-07-05 | 16:10 ET | [8-K](/filings/0001493152-24-026349.md) | 3.01 Delisting notice | 0001493152-24-026349 |
| 2024-06-14 | 16:10 ET | [10-Q](/filings/0001493152-24-023867.md) | Quarterly report, period 2024-04-30 | 0001493152-24-023867 |

Page 1 of 3. [Older](/companies/bctx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.